Protective Effects of the Wenfei Buqi Tongluo Formula on the Inflammation in Idiopathic Pulmonary Fibrosis through Inhibiting the TLR4/MyD88/NF-<i>κ</i>B Pathway

<div>The potential mechanism of the WBT formula for inhibiting the TLR4/MyD88/NF-<i>κ</i>B pathway-mediated inflammation against IPF.</div>

BioMed Research International

fig6

Figure 6

Figure 6: Protective Effects of the Wenfei Buqi Tongluo Formula on the Inflammation in Idiopathic Pulmonary Fibrosis through Inhibiting the TLR4/MyD88/NF-<i>κ</i>B Pathway 

Figure 6 | Protective Effects of the Wenfei Buqi Tongluo Formula on the Inflammation in Idiopathic Pulmonary Fibrosis through Inhibiting the TLR4/MyD88/NF-κB Pathway 